The revised “Pharmaceutical Administration Law” allows the online selling of prescription drugs
On August 26th, the revised “Pharmaceutical Administration Law” was approved by the Twelfth Session of the Thirteenth Standing Committee of the National People’s Congress and will come into effect on December 1st, 2019. The “Pharmaceutical Administration Law” proposed that the Marketing Authorisation Holders and pharmaceutical companies can sell drugs online on the premise of complying with relevant provisions. Vaccines, narcotic drugs, and other drugs under special control are not included.
新《药品管理法》对网售处方药开了绿灯
来源：医药网 2019.08.27
8月26日， 新修订版《药品管理法》经十三届全国人大常委会第十二次会议表决通过，并将自2019年12月1日起施行。法案提出，药品上市许可持有人、药品经营企业可在遵守法案关于药品经营的有关规定的前提下通过网络销售药品。疫苗、麻醉药品等国家实行特殊管理的药品不得在网络上销售。
Catalog of medical insurance (2019 Version) is released
On August 21st, the State Council issued the “National Medicine Catalogue of Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance (2019 version),” which will be implemented from January 1st, 2020. The “Medicine Catalogue” Indicates that each provincial Medical Insurance Bureau should bring all the drugs of the “Medicine Catalogue” into the “Centralised Procurement” and update the drug database according to the use of drugs in local medical institutions and retail pharmacies. Meanwhile, a national unified drug database should be established to realise the unified management of codes of western medicine, Chinese traditional medicine, and hospital-made medicines.
2019版国家医保目录正式发布
来源：医药网 2019.08.21
8月21日，国务院发布《国家基本医疗保险、工伤保险和生育保险药品目录》（以下简称《目录》），并自2020年1月1日起开始实施。《目录》要求，各省级医疗保障部门应及时将《目录》内药品纳入当地药品集中采购范围，并根据辖区内医疗机构和零售药店药品使用情况，及时更新完善药品数据库。同时，应建立完善全国统一的药品数据库，实现西药、中成药、中药饮片、医院制剂的编码统一管理。
Heilongjiang: The detailed rules of drug price supervision is going to be implemented
On August 9th, the Medical Insurance Bureau of the Heilongjiang province issued the “Notification of Supervising Drug Price and Distribution Information.” The “Notification” stipulates that the supervision of drug price and distribution information should be carried from drug manufacturers, distribution enterprises, medical institutions, retail pharmacies, and public sentiment. The mechanisms for information collection, reporting, analysis, investigation, and processing should be improved at the provincial, city, and county levels.
药品价格监测地方细则来了！月月报送、五方联动……
来源：医药网 2019.08.12
8月9日，黑龙江省医保局发布了《关于做好药品价格和配送信息检测工作的通知》（以下简称《通知》）。《通知》指出，应从药品生产企业、配送企业、医疗机构、定点零售药店和社会舆情五个方面开展药品价格和配送信息检测；健全并完善省、市、县三级联动的信息采集、报送、分析、调查、处理机制。
The Xi’an Municipal Government launches the submission of increased purchase of selected drugs(“4+7”)
On August 6th, the Xi’an Municipal Government issued the “Notification on Launching the Submission of Increased Purchase of Selected Drugs in Xi’an from the ‘Office of the Leading Group for the Implementation of Centralized Drug Procurement and Pilot Work’”. It is decided to increase the purchase of selected drugs in Xi’an because its procurement exceeds expectations. Besides, the deferred payment of the increased procurement should be paid in time.
“4+7″采购量完成超预期，启动中选药品增加采购量报送
来源：医药网 2019.08.07
8月6日，西安市发布《落实国家组织药品集中采购和试点工作领导小组办公室关于启动西安地区中选药品增加采购量报送工作的通知》。因西安地区”4+7″准备采购量完成情况已经超过预期，经研究，决定启动西安地区中选药品增加采购量报送工作。同时，对于增加的采购量，应确保及时回款。
Zhejiang takes the lead in implementing DRGs payment
On July 18th, the Zhejiang Medical Insurance Bureau issued the “Opinions on Promoting the Reform of Basic Medical Insurance Payment Methods for Medical Communities in Zhejiang Province,” and plans to implement multiple and composite medical insurance payment methods under total budget management. For inpatient medical services, the payment is mainly based on the DRGs (Diagnosis-Related Groups) system. For long-term and chronic disease inpatient medical services, the “daily payment for each sickbed” will be gradually promoted. For outpatient medical services, the “per-head payment” will be implemented, which also combines the “Contracted Family Doctor Services”.
市场洗牌来了！浙江率先全面推行DRGs点数法付费
来源：医药网 2019.07.19
7月18日，浙江省医保局发布《关于推进全省县域医共体基本医疗保险支付方式改革的意见》，计划全面推行总额预算管理下的多元复合式医保支付方式；对住院医疗服务，主要按DRGs（疾病诊断相关分组）点数法付费；对长期、慢性病住院医疗服务，逐步推行按床日付费；对门诊医疗服务探索结合家庭医生签约服务，实行按人头付费。
“Guideline” for “Internet+Health Care” in Shandong province released
On July 11th, the Shandong Provincial Government issued the “Notification on the Construction Plan for Promoting a Demonstration Province of ‘Internet+Health Care’ from 2019 to 2020.” The “Notification” stipulates that to achieve the real-time exchange and sharing of medical data, the construction of a “traceability system of drugs,” a “pre-warning and detecting system of medicines in short supply,” and a “prescription circulation platform” should be promoted. The “Notification” indicates that the construction of “Internet Hospitals” based on medical institutes is encouraged, and the “consulting or prescribing medicine over the internet” should be widely implemented in Shandong province from 2020.
山东“互联网+医疗健康”的路线图， 来了！
来源：医药网 2019.07.15
核心提示：7月11日，山东省人民政府发布《关于印发山东省推进“互联网+医疗健康”示范省建设行动计划（2019-2020年）的通知》（以下简称《通知》）。《通知》指出，应加快药品追溯体系、短缺药品检测预警系统以及处方流转平台的建设，实现医疗数据的实时交换和共享。《通知》明确，鼓励建设依托医疗机构发展的互联网医院，2020年起应普遍开展互联网诊疗服务。
“List of National Intensive Monitoring Drug” is released
On July 1st, the Medical Administration Bureau of the National Health Commission issued the “Notification on printing the first List of National Intensive Monitoring Drug (Chemicals and Biological Products),” 20 drugs were selected in the “List.” The “Notification” stipulates that all provinces should form a list of provincial intensive monitoring drug on the basis of the national “List” and publish it for use by various medical institutions. All medical institutions should establish a regulatory system for monitoring drugs and strengthen the management of clinical applications of them. At the same time, the prescription management of drugs outside the “List” should also be strengthened.
重磅！国家重点监控药品目录公布
来源：医药网 2019.07.02
核心提示：7月1日，国家卫健委医政医管局发布了《关于印发第一批国家重点监控合理用药药品目录（化药及生物制品）的通知》，共20个药品入选。 《通知》要求， 各省应在《目录》基础上形成省级重点监控合理用药药品目录并公布，以供各类医疗机构参考；各医疗机构要建立重点监控合理用药药品管理制度，加强目录内药品临床应用的全程管理；同时，还应加强目录外药品的处方管理。
“Drug Evaluation Report in 2018” is released
On July 1st, the National Medical Products Administration(NMPA) issued the “Drug Evaluation Report in 2018.” The “Report” shows that the Drug Evaluation Centre of the NMPA reviewed and approved 106 new drugs in 2018. Although the number of applications for registration of new drugs has increased by 47%, the evaluation time has been reduced significantly in comparison to 2017. Benefiting from the accelerated drug evaluation reforms, the number of applications for registration of innovative drugs has increased significantly in 2018, of which 85% were from domestic companies. At the same time, in order to improve the quality of generic drugs, the Drug Evaluation Centre has made every effort to promote the “Quality Consistency Evaluation for Generic Drugs,” and there were eight batches of generic drugs that are involved in comparison to 2018.
《2018年度药品评审报告》发布
来源：中国医药报 2019.07.01
核心提示：7月1日，国家药品监管局发布《2018年度药品评审报告》（以下简称《报告》）。《报告》显示，2018年国家药监局药品评审中心共审评通过106个新药；新药注册申请较2017年增长了47%，但注册申请审评用时明显下降；受益于药审改革加速，2018年创新药注册申请数量大幅增长，其中85%的注册申请来自国内企业；同时，为提升我国仿制药质量，药品审评中心全力推进仿制药治疗和疗效一致性评价工作，2018年全年正式发布了8批参比制剂目录。
A unified national insurance standardized system will be established
On June 27th, the National Health Security Administration(NHSA) issued the “Guideline on the Standardisation of Medical Security.” The “Guideline” indicates that the exchange of medical security information in China has begun to use a common language——the “Coding Standard.” Now, the NHSA has completed four “Coding Standards”. Among them, the “Code and Classification of Medical Insurance Drugs” covers all drugs approved by the NMPA and realizes “one-code-for-one-drug”, which makes it easier for the public to inquire about drug information and provides resource sharing. The “Guideline” also indicates that the NHSA will focus on the standardization of medical insurance funds, medical price management, the medical security system and so on.
建立全国统一医保标准化体系
来源：医药网 2019.06.28
核心提示：6月27日，国家医保局印发《医疗保障标准化工作指导意见》。《意见》指出，我国医疗保障信息交换已经开始使用通用语言——业务编码标准。目前，医保局已经完成了四项编码标准。其中，“医保药品分类与代码”覆盖了经药品监督管理部门批准上市的全部药品，实现了“一物一码”，可便于公众查询以及提供资源共享。《意见》还表明，国家医保局将在医保基金、医药价格管理、医疗保障系统等方面重点实行标准化。
“List of imported drugs that are suggested to be imitated” is released
On June 20th, the National Health Commission issued the initial “List of imported drugs that are suggested to be imitated.” The National Health Commission has cooperated with the National Medical Products Administration and other departments to organise experts to select a total of 34 drugs whose patents expire or patents that are about to expire but have not been filed for registration. The “List” also includes drugs that are in short supply or actively declared by enterprises.
首批鼓励仿制药品目录 34个药品入选
来源：医药网 2019.06.21
核心提示：6月20日，国家卫健委公布《第一批鼓励仿制药品目录建议清单》。国家卫健委联合国家药监局等部门，组织专家从国内专利到期和专利即将到期却尚未提出注册申请、临床供应短缺以及企业主动申报的药品进行遴选，提出共计34个品种。